BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19164206)

  • 41. Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation.
    Lewis A; Mitsuya K; Umlauf D; Smith P; Dean W; Walter J; Higgins M; Feil R; Reik W
    Nat Genet; 2004 Dec; 36(12):1291-5. PubMed ID: 15516931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.
    Kaddar T; Chien WW; Bertrand Y; Pages MP; Rouault JP; Salles G; Ffrench M; Magaud JP
    Leuk Res; 2009 Sep; 33(9):1217-23. PubMed ID: 19195700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia.
    Busche S; Ge B; Vidal R; Spinella JF; Saillour V; Richer C; Healy J; Chen SH; Droit A; Sinnett D; Pastinen T
    Cancer Res; 2013 Jul; 73(14):4323-36. PubMed ID: 23722552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.
    Merimi M; Klener P; Szynal M; Cleuter Y; Kerkhofs P; Burny A; Martiat P; Van den Broeke A
    J Virol; 2007 Jun; 81(11):5929-39. PubMed ID: 17392371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia.
    Ogawa M; Sakashita K; Zhao XY; Hayakawa A; Kubota T; Koike K
    Leuk Res; 2007 May; 31(5):611-21. PubMed ID: 17074388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood and adult ALL: differences in epigenetic lesions associated with cell cycle genes.
    Gutiérrez MI; Siraj AK; Ibrahim MM; Hussain A; Bhatia K
    Am J Hematol; 2005 Oct; 80(2):158-60. PubMed ID: 16184585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
    Lee J; Yoon YS; Chung JH
    Gynecol Oncol; 2008 May; 109(2):270-4. PubMed ID: 18377964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
    Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephrotic syndrome patients.
    Zhang L; Dai Y; Peng W; Lu J; Zhang Y; Wang L
    Am J Nephrol; 2009; 30(6):505-13. PubMed ID: 19797895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global, comparative analysis of tissue-specific promoter CpG methylation.
    Schilling E; Rehli M
    Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
    Yang Q; Kiernan CM; Tian Y; Salwen HR; Chlenski A; Brumback BA; London WB; Cohn SL
    Clin Cancer Res; 2007 Jun; 13(11):3191-7. PubMed ID: 17545522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
    Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B; Stresemann C; Kuner R; Mund C; Musch T; Meister M; Sültmann H; Lyko F
    Cancer Res; 2007 Feb; 67(4):1419-23. PubMed ID: 17308078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
    Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.
    De Bruyne E; Bos TJ; Asosingh K; Vande Broek I; Menu E; Van Valckenborgh E; Atadja P; Coiteux V; Leleu X; Thielemans K; Van Camp B; Vanderkerken K; Van Riet I
    Clin Cancer Res; 2008 May; 14(10):2918-26. PubMed ID: 18483358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
    Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
    Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.